Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released Nov 7, 2022, after the close
10-Q filed Nov 7, 2022, 38 days after period end · 0000950170-22-022631
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$24.83M | -$18.43M | -$25.55M | -$6.55M |
| EPS Diluted | -$0.63 | -$0.47 | -$0.84 | -$3.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR